Nateglinide and disease progression Patient Reports February 11, 2012

Nateglinide Side Effects Report #5621715-3
Nateglinide side effect was reported by a Physician from BRAZIL on Feb 01, 2008. Female patient, 79 years of age, weighting 154.3 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, arrhythmia , hypertension and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: abdominal pain , arrhythmia , disease progression, dyspnoea, ventricular fibrillation, ventricular tachycardia. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, CARVEDILOL, AMLODIPINE, HYDROCHLOROTHIAZIDE, CAPTOPRIL, ACETYLSALICYLATE. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5624227-6
Nateglinide side effect was reported by a Physician from BRAZIL on Feb 08, 2008. Female patient, 79 years of age, weighting 154.3 lb, was diagnosed with glucose tolerance impaired, arrhythmia , hypertension, dyslipidaemia and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: abdominal pain , arrhythmia , atrioventricular block, disease progression, dyspnoea, electrocardiogram qt prolonged, ventricular fibrillation, ventricular tachycardia. Nateglinide dosage: 60 MG, UNK. During the same period patient was treated with CARVEDILOL, AMLODIPINE, CAPTOPRIL, ACETYLSALICYLATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5624228-8
Nateglinide side effect was reported by a Physician from BRAZIL on Feb 08, 2008. Female patient, 79 years of age, weighting 154.3 lb, was diagnosed with glucose tolerance impaired, arrhythmia , hypertension, dyslipidaemia and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: abdominal pain , arrhythmia , atrioventricular block, disease progression, dyspnoea, electrocardiogram qt prolonged, ventricular fibrillation, ventricular tachycardia. Nateglinide dosage: 60 MG, UNK. During the same period patient was treated with CARVEDILOL, AMLODIPINE, CAPTOPRIL, ACETYLSALICYLATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #4952184-4
Nateglinide side effect was reported by a Physician from UNITED STATES on Mar 13, 2006. Female patient, 79 years of age, weighting 270.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension, prophylaxis and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: atrial flutter, cardiac ablation, cardiac murmur, disease progression, dizziness , dyspnoea, feeling abnormal, fibrin d dimer increased, heart rate increased. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, ATENOLOL, ASPIRIN, VASOTEC RPD, LISINOPRIL, MACROBID. Patient was hospitalized. Patient recovered.


Nateglinide Side Effects Report #5327042-6
Nateglinide side effect was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 77 years of age, weighting 144.0 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: abdominal discomfort, abdominal distension, abdominal tenderness, benign colonic neoplasm, bradycardia, cardiac pacemaker insertion, colectomy, disease progression, inflammation. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #4874983-X
Nateglinide side effect was reported by a Physician from RUSSIAN FEDERATION on Dec 28, 2005. Female patient, 76 years of age, weighting 216.1 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina pectoris, bronchitis chronic, cholecystitis chronic, coronary artery disease , disease progression, dizziness , dyspnoea, hypertension. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, CARDIKET, VERAPAMIL, HYPOTHIAZID, MONO MACK. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5317624-X
Nateglinide side effect was reported by a Physician from CHILE on Apr 26, 2007. Male patient, 69 years of age, weighting 191.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina unstable, arterial injury, arterial occlusive disease, cardiac enzymes increased, chest pain , disease progression, myocardial infarction. Nateglinide dosage: unknown. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5356939-6
Nateglinide side effect was reported by a Physician from CHILE on June 07, 2007. Male patient, 69 years of age, weighting 191.8 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: angina unstable, arterial injury, arterial occlusive disease, cardiac enzymes increased, chest pain , disease progression, glucose tolerance impaired, myocardial infarction, vascular bypass graft. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5470575-2
Nateglinide side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 67 years of age, weighting 267.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: arrhythmia , disease progression, dizziness , extrasystoles, implantable defibrillator insertion, palpitations, presyncope, sinus bradycardia, ventricular extrasystoles. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE, LASIX. Patient was hospitalized. Patient recovered.


Nateglinide Side Effects Report #5475398-6
Nateglinide side effect was reported by a Physician from UNITED STATES on Sept 24, 2007. Male patient, 67 years of age, weighting 267.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: arrhythmia , cardiac ablation, disease progression, dizziness , extrasystoles, implantable defibrillator insertion, palpitations, presyncope, sinus bradycardia. Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, METOPROLOL, LASIX. Patient was hospitalized. Patient recovered.

Nateglinide Side Effects Report #5502585-0
Nateglinide side effect was reported by a Physician from UNITED STATES on Oct 24, 2007. Male patient, 67 years of age, weighting 267.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: arrhythmia , cardiac ablation, disease progression, dizziness , extrasystoles, implantable defibrillator insertion, palpitations, pneumonia . Nateglinide dosage: unknown. During the same period patient was treated with VALSARTAN, METOPROLOL, LASIX. Patient was hospitalized. Patient died on 09/30/2007.

Nateglinide Side Effects Report #5723314-1
Nateglinide side effect was reported by a Physician from UNITED STATES on Apr 25, 2008. Male patient, 67 years of age, weighting 267.6 lb, was diagnosed with glucose tolerance impaired, cardiovascular disorder, hypertension and was treated with Nateglinide. After drug was administered, patient experienced the following side effects: arrhythmia , arteriosclerosis, cardiac ablation, disease progression, dizziness , extrasystoles, hypertension, implantable defibrillator insertion, palpitations. Nateglinide dosage: unknown. During the same period patient was treated with METOPROLOL TARTRATE, METOPROLOL TARTRATE, LASIX. Patient was hospitalized. Patient died on 09/30/2007.